Literature DB >> 9678808

Review article: short chain fatty acids in health and disease.

S I Cook1, J H Sellin.   

Abstract

Short chain fatty acids (SCFAs) have been the subject of much research over the past few decades. They play a vital role in maintenance of colonic integrity and metabolism. They are produced when dietary fibre is fermented by colonic bacteria. SCFAs are avidly absorbed in the colon, at the same time as sodium and water absorption and bicarbonate secretion. Once absorbed, SCFAs are used preferentially as fuel for colonic epithelial cells and have trophic effects on the epithelium. Clinically, SCFAs have been studied as possible therapeutic agents in diversion colitis, ulcerative colitis, radiation proctitis, pouchitis and antibiotic-associated diarrhoea. Although some promising effects have been observed in uncontrolled studies, a specific therapeutic role for SCFAs remains to be defined. SCFAs may be the effector of the beneficial role of fibre in prevention of colon cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9678808     DOI: 10.1046/j.1365-2036.1998.00337.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  133 in total

1.  Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-κB pathway in RAW264.7 cells.

Authors:  Tengfei Liu; Jing Li; Yuxin Liu; Nan Xiao; Haitao Suo; Kun Xie; Chunliu Yang; Chen Wu
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

Review 2.  Probiotics, enteric and diarrheal diseases, and global health.

Authors:  Geoffrey A Preidis; Colin Hill; Richard L Guerrant; B S Ramakrishna; Gerald W Tannock; James Versalovic
Journal:  Gastroenterology       Date:  2010-11-12       Impact factor: 22.682

3.  Effect of Synbiotic Therapy on Gut-Derived Uremic Toxins and the Intestinal Microbiome in Patients with CKD.

Authors:  Nosratola D Vaziri
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-15       Impact factor: 8.237

Review 4.  Microbiota and the control of blood-tissue barriers.

Authors:  Maha Al-Asmakh; Lars Hedin
Journal:  Tissue Barriers       Date:  2015-05-29

5.  An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota.

Authors:  Shokouh Ahmadi; Shaohua Wang; Ravinder Nagpal; Rabina Mainali; Sabihe Soleimanian-Zad; Dalane Kitzman; Hariom Yadav
Journal:  J Vis Exp       Date:  2019-07-31       Impact factor: 1.355

6.  Obese Mice Losing Weight Due to trans-10,cis-12 Conjugated Linoleic Acid Supplementation or Food Restriction Harbor Distinct Gut Microbiota.

Authors:  Laura J den Hartigh; Zhan Gao; Leela Goodspeed; Shari Wang; Arun K Das; Charles F Burant; Alan Chait; Martin J Blaser
Journal:  J Nutr       Date:  2018-04-01       Impact factor: 4.798

7.  Food for thought.

Authors:  Joseph H Sellin
Journal:  Curr Gastroenterol Rep       Date:  2009-10

8.  A novel facet to consider for the effects of butyrate on its target cells. Focus on "The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein".

Authors:  Ravinder K Gill; Pradeep K Dudeja
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-10       Impact factor: 4.249

Review 9.  Effects of gut microbes on nutrient absorption and energy regulation.

Authors:  Rosa Krajmalnik-Brown; Zehra-Esra Ilhan; Dae-Wook Kang; John K DiBaise
Journal:  Nutr Clin Pract       Date:  2012-02-24       Impact factor: 3.080

10.  A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids.

Authors:  Mark A Underwood; Nita H Salzman; Stephen H Bennett; Melissa Barman; David A Mills; Angela Marcobal; Daniel J Tancredi; Charles L Bevins; Michael P Sherman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.